DexCom, Inc. (DXCM) Stock Analysis

DexCom, Inc. (DXCM) Stock Analysis — AI Research | MarketCI

DXCM

Market Closed

DexCom, Inc.

NASDAQHealthcare Medical - Devices

10.20K employees

CEO: Jacob Steven Leach

Founded: 2005

$72.47

+$0.00(+NaN%)

Market Cap

27.96B

Beta

1.44

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

DXCM Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for DXCM built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Hold

Pass %

57.14%

Score

4/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$47.38

AI Price Target

Machine learning • Price prediction

$66.96

Market Sentiment

News & social media analysis

0.06

Value Investor Price

Classic value analysis

$9.46

Financial Health

Bankruptcy risk assessment

5.97

Quality Score

Financial strength rating

8.00

AI Investment Grade

Deep analysis of filings & news

78.00

Key Investment Highlights

Important factors affecting DXCM investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

78.05% Excellent

Conditions Met

32.00/41.00

Due Diligence Score

78.05%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Pass
	Pass
	Pass
	Pass
	Pass

Showing 1 to 6 of 46 conditions